These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15877012

  • 1. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
    Tomlinson JW.
    Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
    [Abstract] [Full Text] [Related]

  • 2. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M.
    Handb Exp Pharmacol; 2011 Mar; (203):127-46. PubMed ID: 21484570
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
    Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M, Mikhailidis DP.
    Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056
    [Abstract] [Full Text] [Related]

  • 7. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory.
    Seckl JR, Walker BR.
    Trends Endocrinol Metab; 2004 Nov; 15(9):418-24. PubMed ID: 15519888
    [Abstract] [Full Text] [Related]

  • 8. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
    Schnackenberg CG.
    Curr Opin Investig Drugs; 2008 Mar; 9(3):295-300. PubMed ID: 18311666
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.
    Tomlinson JW, Stewart PM.
    Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):92-9. PubMed ID: 16929377
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR, Andrew R.
    Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM, Seckl JR.
    Front Horm Res; 2008 Nov; 36():146-164. PubMed ID: 18230901
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Wake DJ, Walker BR.
    Mol Cell Endocrinol; 2004 Feb 27; 215(1-2):45-54. PubMed ID: 15026174
    [Abstract] [Full Text] [Related]

  • 16. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD, Azevedo I, Monteiro R, Martins MJ.
    Diabetes Obes Metab; 2012 Oct 27; 14(10):869-81. PubMed ID: 22321826
    [Abstract] [Full Text] [Related]

  • 17. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE, Walker BR.
    J Pharmacol Exp Ther; 2003 Apr 27; 305(1):167-72. PubMed ID: 12649365
    [Abstract] [Full Text] [Related]

  • 18. Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes.
    Gathercole LL, Stewart PM.
    J Steroid Biochem Mol Biol; 2010 Oct 27; 122(1-3):21-7. PubMed ID: 20347978
    [Abstract] [Full Text] [Related]

  • 19. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C.
    Int J Obes (Lond); 2007 Dec 27; 31(12):1826-31. PubMed ID: 17593901
    [Abstract] [Full Text] [Related]

  • 20. Discovery of novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Su X, Vicker N, Trusselle M, Halem H, Culler MD, Potter BV.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):169-73. PubMed ID: 18775471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.